(Q36589340)

15 August 2017

1 reference

title

Clinical aspects of parvovirus B19 infection (English)

1 reference

15 August 2017

1

Broliden K

1 reference

15 August 2017

2

Tolfvenstam T

1 reference

15 August 2017

Norbeck O

3

1 reference

PubMed ID

16961667

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Journal of Internal Medicine

15 August 2017

1 reference

15 August 2017

260

1 reference

15 August 2017

285-304

1 reference

15 August 2017

4

1 reference

Parvovirus-like particles in human sera

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

B19 virus genome diversity: epidemiological and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Identification and characterization of a second novel human erythrovirus variant, A6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Genetic diversity within human erythroviruses: identification of three genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

A new parvovirus genotype persistent in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Cloning of a human parvovirus by molecular screening of respiratory tract samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

A human parvovirus-like virus inhibits haematopoietic colony formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Seroprevalence of viral childhood infections in Eritrea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 transmitted by bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Outbreak of human parvovirus B19 in hospital workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Human parvovirus B19 and blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Inactivation of parvovirus B19 during pasteurization of human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

High-sensitivity PCR detection of parvovirus B19 in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Experimental parvoviral infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Occupational Risk Factors for Infection with Parvovirus B19 among Pregnant Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Rheumatic manifestations of parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

The cutaneous manifestations of human parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Epidemiology of human parvovirus B19 in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Myocarditis associated with parvovirus B19 infection in two siblings with merosin-deficient congenital muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Myocarditis caused by parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Myopericarditis due to parvovirus B19 in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

A rare case of acute 'infective' myocardial infarction triggered by acute parvovirus B19 myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Gloves and socks syndrome: early and late histopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Association of human parvovirus B19 infection with acute meningoencephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

21 January 2018

Human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Prevalence of Parvovirus B19 in Liver Tissue: No Association with Fulminant Hepatitis or Hepatitis‐Associated Aplastic Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 infection and bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 infection in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Revised clinical presentation of parvovirus B19-associated intrauterine fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Detection of human parvovirus B19 infection in first-trimester fetal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Placental cellular immune response in women infected with human parvovirus B19 during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

High prevalence of viral genomes and inflammation in peripartum cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Impaired gamma interferon responses against parvovirus B19 by recently infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Prolonged activation of virus-specific CD8+T cells after acute B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Virus-specific CD8+ T-cell memory determined by clonal burst size

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Detection of parvovirus B19, cytomegalovirus and enterovirus infections in cases of intrauterine fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Fetal parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Intrauterine therapy for parvovirus B19 infected symptomatic fetus using B19 IgG-rich high titer gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Recurrent erythema in patients with long-term parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

HUMAN PARVOVIRUS ARTHROPATHY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Reconstituted Immunity against Persistent Parvovirus B19 Infection in a Patient with Acquired Immunodeficiency Syndrome after Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Increase in B19 Viral Load Prior to Relapse of Anaemia in an AIDS Patient with Persistent B19 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Clinical manifestations of human parvovirus B19 in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Extent of sequence variability in a genomic region coding for capsid proteins of B19 parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Aberrant cellular immune responses in humans infected persistently with parvovirus B19

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 infection: association with third-trimester intrauterine fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Frequency of human parvovirus B19 infection in intrauterine fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Slow clearance of human parvovirus B19 viremia following acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

Parvovirus B19 infection in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2006.01697.X

10.1111/J.1365-2796.2006.01697.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16961667